Organisation paid for research Program year 2024 Source: CMS Open Payments

Vanmeter Pediatric Endocrinology

Neither a doctor nor a teaching hospital

Research payments

$60,161

29 payments

Through program year 2024, Vanmeter Pediatric Endocrinology is reported as receiving $60,161 in research payments, across 29 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$734	1
2023	Research	$8,161	2
2022	Research	$4,289	4
2021	Research	$6,664	4
2020	Research	$21,575	9
2019	Research	$18,738	9

Breakdown

Who paid Research payments · program years 2019–2024

AbbVie, Inc. $60,161 29 payments

Studies the money was for Research payments · program years 2019–2024

M16-904 $40,313 18 payments
A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Leuprolide Acetate 45mg 6-Month Formulation in Children With Central Precocious Puberty (CPP) $12,450 6 payments
A Phase 3, Multicenter, Open-Label, Two-Part Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Leuprolide Acetate 45mg 6-Month Depot Formulation in Children with Central Precocious Puberty (CPP) $6,664 4 payments
A Study to Evaluate Safety Efficacy Pharmacokinetics and Pharmacodynamics of Leuprolide Acetate 45mg 6-Month Formulation in Children With Central Precocious Puberty (CPP) $734 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.